 |
|
|
|||||
The Indian stock market is undergoing a correction. Some sectors like auto and microfinance are facing difficulties. However, the long-term outlook for the market remains positive. Investors are advised to focus on companies with strong fundamentals and a history of good results. The days of wild speculation and easy returns are over.
Category:
News and Media
Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to 'Reduce' with a revised target price of Rs 1,625, citing improved core business performance.
Category:
News and Media
SEBI issued a third advisory warning investors about unauthorized platforms offering virtual trading, paper trading, and fantasy games. It urged investing only through registered intermediaries to avoid financial losses and fraud.
Category:
News and Media
Ola Electric Share Price: Ola Electric Mobility's shares dipped 7% as an 18.2 crore share lock-in period ended, allowing certain investors to sell their previously restricted shares. This lock-in period, common after IPOs, aims to stabilize stock prices. The company's shares, despite a recent surge, have experienced declines over the past month. An upcoming board meeting will address financial results.
Category:
News and Media
Pharma and healthcare mutual funds have yielded impressive returns in 2024. The sector benefited from resilience amidst corrections in other sectors and steady growth in the domestic market. Experts suggest a cautious approach to investment due to current valuations. A phased allocation strategy of 10-15% is recommended, with potential for increasing allocation over time.
Category:
News and Media
Sites : [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] next »